Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cindy Seidel-Dugan"'
Autor:
Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3596c09c2f37405a823df42493709240
Autor:
Christopher Nirschl, Kristin Morris, Heather Brodkin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan, Ethika Tyagi, Josue Canales, Dan Hicklin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/18dad127330e419b9eb3381e399e2e74
Autor:
Zoe Steuert, Christopher J. Nirschl, Jenna Sullivan, Ethika Tyagi, Cindy Seidel-Dugan, Philipp Steiner, Dan Hicklin, William Winston, Heather Brodkin, Nesreen Ismail, Josue Canales, Kristin Morris, Andres Salmeron
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundInterferon α (IFNα) was the first cytokine clinically tested as a cancer therapy. IFNα is a member of the type-I IFN family and activates immune responses either directly by engaging IFNα receptors (IFNAR) ubiquitously expressed on immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7b6ef2562a3a899e8884ac7d8bd273
https://doaj.org/article/18dad127330e419b9eb3381e399e2e74
https://doaj.org/article/18dad127330e419b9eb3381e399e2e74
Autor:
Daniel J. Hicklin, Jenna Sullivan, Andres Salmeron, Ethika Tyagi, Philipp Steiner, Kristin Morris, Heather Brodkin, Christopher J. Nirschl, Zoe Steuert, William Winston, Josue Canales, Cindy Seidel-Dugan, Nesreen Ismail, Randi Isaacs
Publikováno v:
Blood. 138:2258-2258
Systemic therapy with proinflammatory immune modulators to activate anti-tumor immunity is a promising approach to treat cancer. However, poor pharmacokinetic properties and dose-limiting toxicities such as inflammation, cytokine release syndrome, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5829711860470be4bce00dda5574a01d
https://doi.org/10.1182/blood-2021-152758
https://doi.org/10.1182/blood-2021-152758
Autor:
Daniel J. Hicklin, Cindy Seidel-Dugan, Heather Brodkin, Nesreen Ismail, William Winston, Philipp Steiner, Zoe Steuert, Andres Salmeron, Jenna Sullivan, Kristin Morris, Christopher J. Nirschl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundCancer immunotherapy has established itself as the fourth pillar of cancer treatment thanks to the clinical success of checkpoint inhibitors. However, durable anti-tumor responses following immunotherapy are still limited to certain cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811f4051170ecc39356f00f034914092
https://doi.org/10.1136/jitc-2021-sitc2021.718
https://doi.org/10.1136/jitc-2021-sitc2021.718
Autor:
Christopher J. Nirschl, Philipp Steiner, Cindy Seidel-Dugan, Dan Hicklin, Zoe Steuert, William Winston, Kristin Morris, Andres Salmeron, Nesreen Ismail, Jenna Sullivan, Heather Brodkin
Publikováno v:
Cancer Research. 81:1716-1716
Systemic therapy with proinflammatory immune modulators is a promising approach to treat cancer by activating innate and adaptive anti-tumor immunity. However, dose-limiting toxicities such as inflammation, cytokine release syndrome, and tissue damag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0074afc099a8c0560481e878f253f0e
https://doi.org/10.1158/1538-7445.am2021-1716
https://doi.org/10.1158/1538-7445.am2021-1716